What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.73%Below 5Y avg (1.88%)
Annual Rate
KRW 100.00Paid annual
Payout Ratio
44.3%Sustainable
Last Ex-Dividend
Jun 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
277.05BKRW
195.57M · vs all stocks (USD)
Updated Jul 14, 2026
Trailing P/E
31.11x
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Revenue (TTM)
160.42BKRW
113.24M · vs all stocks (USD)
Updated Jul 14, 2026
Profit Margin
8.38%
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Beta
1.18x
vs all stocks
Updated Jul 14, 2026
52-Week Change
37.34%
vs all stocks
Updated Jul 14, 2026
Market Capitalization
277.05BKRW
195.57M · vs all stocks (USD)
Updated Jul 14, 2026
Enterprise Value
292.16BKRW
206.23M · vs all stocks (USD)
Updated Jul 14, 2026
Trailing P/E
31.11x
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Forward P/E
16.41x
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
PEG Ratio
-0.0527x
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Price to Sales (TTM)
1.88x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 1.73×.Updated Jul 14, 2026
Price to Book (MRQ)
1.15x
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Enterprise to Revenue
1.82x
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Enterprise to EBITDA
12.51x
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Gross Margin
33.58%
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Profit Margin
8.38%
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Operating Margin
13.43%
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Return on Assets (TTM)
4.31%
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Return on Equity (TTM)
7.28%
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Revenue (TTM)
160.42BKRW
113.24M · vs all stocks (USD)
Updated Jul 14, 2026
Revenue per Share (TTM)
8.09KKRWUpdated Jul 14, 2026
Quarterly Revenue Growth
36.90%
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Gross Profit (TTM)
52.37BKRW
36.97M · vs all stocks (USD)
Updated Jul 14, 2026
EBITDA (TTM)
23.14BKRW
16.34M · vs all stocks (USD)
Updated Jul 14, 2026
Net Income (TTM)
13.45BKRW
9.49M · vs all stocks (USD)
Updated Jul 14, 2026
Quarterly Earnings Growth (YoY)
36.94%
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Operating Cash Flow (TTM)
27.09BKRW
19.13M · vs all stocks (USD)
Updated Jul 14, 2026
Levered Free Cash Flow (TTM)
1.75BKRW
1.23M · vs all stocks (USD)
Updated Jul 14, 2026
Trailing Annual Dividend Rate
100.00KRWUpdated Jul 14, 2026
Trailing Annual Dividend Yield
0.73%
vs all stocks
Updated Jul 14, 2026
5-Year Average Dividend Yield
1.88%
vs all stocks
Updated Jul 14, 2026
Payout Ratio
44.31%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 22.68%.Updated Jul 14, 2026
Minority Interest (Equity)
43.08BKRWFY2025 · Dec 31, 2025
Revenue
150.38BKRWFY2025 · Dec 31, 2025
Cost of Goods Sold
103.40BKRWFY2025 · Dec 31, 2025
Gross Profit
46.98BKRWFY2025 · Dec 31, 2025
Operating Income
14.29BKRW
10.09M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
13.76BKRWFY2025 · Dec 31, 2025
Income Tax Expense
2.71BKRWFY2025 · Dec 31, 2025
Net Income
11.05BKRWFY2025 · Dec 31, 2025
EBIT
13.89BKRWFY2025 · Dec 31, 2025
EBITDA (Income Statement)
17.59BKRWFY2025 · Dec 31, 2025
Research & Development
3.66BKRWFY2025 · Dec 31, 2025
Selling, General & Administrative
7.17BKRWFY2025 · Dec 31, 2025
Other Operating Expenses
1.51BKRWFY2025 · Dec 31, 2025
Non-operating Interest Income
1.67BKRWFY2025 · Dec 31, 2025
Non-operating Interest Expense
131.41MKRWFY2025 · Dec 31, 2025
Net Income from Continuing Operations
11.05BKRWFY2025 · Dec 31, 2025
Minority Interests (P&L)
-2.34BKRWFY2025 · Dec 31, 2025
Operating Cash Flow
-3.99BKRWFY2025 · Dec 31, 2025
Free Cash Flow
-18.78BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
28.89BKRWFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
11.05BKRWFY2025 · Dec 31, 2025
Stock-based Compensation
767.96MKRWFY2025 · Dec 31, 2025
Other Non-cash Items
-1.54BKRWFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-3.04BKRWFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-11.22BKRWFY2025 · Dec 31, 2025
Capital Expenditures
-14.79BKRWFY2025 · Dec 31, 2025
Net Intangibles (CF)
-219.00MKRWFY2025 · Dec 31, 2025
Purchase of Investments
-52.37MKRWFY2025 · Dec 31, 2025
Sale of Investments
15.05BKRWFY2025 · Dec 31, 2025
Other Investing Activity
284.54MKRWFY2025 · Dec 31, 2025
Net Investing Cash Flow
493.58MKRWFY2025 · Dec 31, 2025
Long-term Debt Issuance
10.00BKRWFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.98BKRWFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-171.94MKRWFY2025 · Dec 31, 2025
Common Stock Repurchase
-977.57MKRWFY2025 · Dec 31, 2025
Other Financing Charges
-100.00MKRWFY2025 · Dec 31, 2025
Net Financing Cash Flow
15.10BKRWFY2025 · Dec 31, 2025
Shares Outstanding
20.19MSharesUpdated Jul 14, 2026
Float Shares
14.15MSharesUpdated Jul 14, 2026
% Held by Insiders
29.91%
vs all stocks
Updated Jul 14, 2026
% Held by Institutions
10.73%
vs all stocks
Updated Jul 14, 2026
Total Cash (MRQ)
73.56BKRW
51.93M · vs all stocks (USD)
Updated Jul 14, 2026
Total Cash per Share (MRQ)
3.64KKRWUpdated Jul 14, 2026
Total Debt (MRQ)
11.62BKRW
8.20M · vs all stocks (USD)
Updated Jul 14, 2026
Total Debt to Equity (MRQ)
0.0481x
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Current Ratio (MRQ)
3.64x
vs Scientific & Technical Instruments peers
Updated Jul 14, 2026
Book Value per Share (MRQ)
11.97KKRWUpdated Jul 14, 2026
Total Assets
297.98BKRW
210.34M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
123.40BKRWFY2025 · Dec 31, 2025
Total Liabilities
56.18BKRWFY2025 · Dec 31, 2025
Total Non-current Assets
174.58BKRWFY2025 · Dec 31, 2025
Total Non-current Liabilities
28.21BKRWFY2025 · Dec 31, 2025
Total Current Liabilities
27.97BKRWFY2025 · Dec 31, 2025
Cash
7.95MKRWFY2025 · Dec 31, 2025
Cash Equivalents
28.88BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents
28.89BKRWFY2025 · Dec 31, 2025
Other Short-term Investments
35.16BKRWFY2025 · Dec 31, 2025
Accounts Receivable
12.01BKRWFY2025 · Dec 31, 2025
Inventory
29.06BKRWFY2025 · Dec 31, 2025
Accounts Payable
6.96BKRWFY2025 · Dec 31, 2025
Short-term Debt
571.47MKRWFY2025 · Dec 31, 2025
Other Current Liabilities
-530.00KRWFY2025 · Dec 31, 2025
Long-term Debt
10.71BKRWFY2025 · Dec 31, 2025
Other Non-current Liabilities
240.00KRWFY2025 · Dec 31, 2025
Common Stock (Book)
10.16BKRWFY2025 · Dec 31, 2025
Retained Earnings
71.92BKRWFY2025 · Dec 31, 2025
Total Shareholders' Equity
241.80BKRW
170.69M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
15.03MKRWFY2025 · Dec 31, 2025
52-Week Low
9.27KKRWUpdated Jul 14, 2026
52-Week High
31.70KKRWUpdated Jul 14, 2026
52-Week Change
37.34%
vs all stocks
Updated Jul 14, 2026
Beta
1.18x
vs all stocks
Updated Jul 14, 2026
50-Day MA
20.04KKRWUpdated Jul 14, 2026
200-Day MA
20.52KKRWUpdated Jul 14, 2026
Avg 10-Day Volume
192.48KSharesUpdated Jul 14, 2026
Avg 30-Day Volume
235.32KSharesUpdated Jul 14, 2026
Diluted EPS (TTM)
441.00KRWUpdated Jul 14, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 1.15×, lower than 95% of its Scientific & Technical Instruments peers (median 3.34×)Notable
Cash Backing With Revenue And Income StreaksPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Cash Backing With Revenue And Income StreaksPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Cash Backing With Revenue And Income StreaksPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated